
A high-conviction short-selling opportunity exists in the quantum computing sector, which one analyst dismisses as "fraud and hype" with no viable products. This bearish view targets speculative stocks like IonQ (IONQ), Rigetti Computing (RGTI), and D-Wave Quantum (QBTS), with a prediction they will eventually go to zero. In contrast, a strong bullish call was made on the biotech company Abivax (ABVX). Citing deep expertise in the drug industry, the analyst projects ABVX stock has the potential to reach a price target of $200. For investors seeking lower-risk exposure to the broader AI theme, established tech giants like Microsoft (MSFT) and Google (GOOGL) offer a more fundamentally sound alternative.

By @realmartinshkreli
Investing, music, science, math, technology, programming, medicine and more!